DR. MARTIN ALAN HYMAN O.D.
Prescription History 1255464335
Optometrist in Los Angeles, CA

Active since March 14, 2007
918 WESTWOOD BLVD, LOS ANGELES, CA 90024(310) 208-3913 Get Directions

NPPES record last updated: July 8, 2007. Verified against the NPPES registry weekly; last sync: October 25, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. MARTIN ALAN HYMAN O.D., an active Optometrist specialist practicing in Los Angeles, CA. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 14 documented patient claims. Among these therapy options, the most frequently utilized medication is Tobramycin-Dexamethasone, which accounts for 14 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
14
Total Claims
14
30-Day Fills
Tobramycin-Dexamethasone
Most Prescribed · 14 claims
View details
1 medication · 2024 Medicare Part D
Medicare Part D medications prescribed by DR. MARTIN ALAN HYMAN O.D. in 2024, with prescription volumes, average cost per fill, and CA state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other CA PrescribersVs. CA Avg
Tobramycin-DexamethasoneTobramycin/Dexamethasone14$47.56▼ Less than typical

About Tobramycin-Dexamethasone: This medication is used to treat or prevent eye infections. Show more ▾

This medication contains two drugs. Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. Dexamethasone belongs to a class of drugs called corticosteroids. It works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

In 2024, this provider wrote 14 Medicare prescriptions for Tobramycin-Dexamethasone, about a third of the volume of the typical California prescriber of this medication (48). Medicare paid an average of $47.56 per fill, versus $40.37 statewide.

How often this provider prescribes it

This provider
14
CA average
48.0

This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$47.56
CA average
$40.37

Gross Part D cost per fill; not the patient's out-of-pocket price.

14
30-Day Fills
standardized to 30-day supplies
215
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average CA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the CA average cost per fill.

About this data. The prescription history for DR. MARTIN ALAN HYMAN O.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Los Angeles, CA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among CA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.